首页> Journal of molecular medicine (Berlin, Germany)> Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain.

Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain.

导出 OA

翻译打印收藏纠错

第一作者： Amanda M,Hamilton

第一单位： Robarts Research Institute, University of Western Ontario, 1151 Richmond St N, London, ON, N6A 5B7, Canada. hamilton@robarts.ca.

作者： Amanda M,Hamilton ^[1] ; Sallouha,Aidoudi-Ahmed ^[2] ; Shweta,Sharma ^[2] ; Venkata R,Kotamraju ^[2] ; Paula J,Foster ^[3] ; Kazuki N,Sugahara ^[2] ; Erkki,Ruoslahti ^[4] ; Brian K,Rutt ^[5]

作者单位： Robarts Research Institute, University of Western Ontario, 1151 Richmond St N, London, ON, N6A 5B7, Canada. hamilton@robarts.ca. ^[1] Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA. ^[2] Robarts Research Institute, University of Western Ontario, 1151 Richmond St N, London, ON, N6A 5B7, Canada. ^[3] Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.;Center for Nanomedicine and Department of Cell, Molecular and Developmental Biology, University of California, Santa Barbara, CA, USA. ^[4] Radiological Sciences Laboratory, Stanford University School of Medicine, Stanford, CA, USA. ^[5]

关键词 Brain metastasis Cell tracking Magnetic resonance imaging Nanoparticle Tumor growth inhibition iRGD